PHASE IIB RANDOMIZED. PLACEBO-CONTROLLED TRIAL OF AN NSAID FOR THE MOD-261025140

$0N01FY2005CNNIH

Cleveland Clinic Foundation, Cleveland OH

Investigators

View original record on NIH RePORTER →